What are the likely etiologies, diagnostic work‑up, and management for a 70‑year‑old patient with dyspnea, bilateral pedal edema, and an echocardiogram demonstrating restrictive cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Restrictive Cardiomyopathy in a 70-Year-Old: Etiologies, Diagnostic Work-Up, and Management

In a 70-year-old with dyspnea, pedal edema, and restrictive cardiomyopathy on echocardiogram, the most critical first step is to distinguish between constrictive pericarditis (which is surgically curable) and infiltrative/restrictive myocardial disease (which requires disease-specific therapy), as this distinction fundamentally alters both prognosis and treatment. 1

Most Likely Etiologies in This Age Group

The differential diagnosis in a 70-year-old includes:

  • Cardiac amyloidosis (most common infiltrative cause at this age, particularly AL or TTR amyloidosis) 2, 3
  • Constrictive pericarditis (mimics restrictive cardiomyopathy but is surgically curable) 1
  • Sarcoidosis (can present with restrictive physiology and ventricular arrhythmias) 2
  • Hemochromatosis (iron deposition in myocardium) 2
  • Radiation-induced fibrosis (if prior chest radiation) 2
  • Idiopathic restrictive cardiomyopathy (diagnosis of exclusion) 2, 3

Diagnostic Algorithm: Distinguishing the Cause

Step 1: Constrictive Pericarditis vs. Restrictive Cardiomyopathy

This is the most critical distinction because constrictive pericarditis is curable with pericardiectomy, while restrictive cardiomyopathy requires disease-specific medical therapy. 1

On the existing echocardiogram, look for:

  • Septal bounce (ventricular interdependence) and respiratory variation of mitral E velocity >25% strongly favor constriction 1
  • Tissue Doppler e' velocity >8.0 cm/s favors constriction (relatively preserved myocardial relaxation) 1
  • Sparkling or granular myocardial texture, thickened interatrial septum, thickened AV valves, or small pericardial effusion suggest infiltrative disease (amyloidosis) 2
  • Biatrial enlargement with normal or small ventricular size is seen in both conditions 2, 3

Order cardiac CT immediately:

  • Pericardial thickness >3.0 mm or pericardial calcification confirms constrictive pericarditis 1

If CT shows normal pericardium, proceed to cardiac MRI:

  • Late gadolinium enhancement patterns identify specific infiltrative causes (amyloidosis shows diffuse subendocardial or transmural enhancement; sarcoidosis shows patchy mid-wall enhancement) 1

Step 2: If Constrictive Pericarditis is Suspected

Measure CRP immediately to determine if there is active inflammation (potentially reversible with anti-inflammatory therapy) versus chronic fibrosis/calcification (requires pericardiectomy) 4

  • If CRP is elevated and cardiac MRI shows pericardial enhancement, consider empiric anti-inflammatory therapy (colchicine, NSAIDs, or corticosteroids) 4
  • If CRP is normal with severe symptoms, the patient has chronic constriction and should not have pericardiectomy delayed waiting for anti-inflammatory trials 4

Proceed to cardiac catheterization to confirm hemodynamics:

  • RVEDP and LVEDP equal (within 5 mmHg) and RV systolic pressure <50 mmHg confirm constriction 1
  • Refer for pericardiectomy if confirmed, with better outcomes when performed early 1

Step 3: If Restrictive Cardiomyopathy is Confirmed

Order the following tests to identify the specific etiology:

For amyloidosis (most common at age 70):

  • Serum and urine protein electrophoresis with immunofixation to detect AL amyloidosis 3
  • Serum free light chains (kappa/lambda ratio) 3
  • Technetium-99m pyrophosphate (PYP) scan: Grade 2-3 cardiac uptake with absent monoclonal protein confirms TTR (transthyretin) amyloidosis without need for biopsy 3
  • If PYP is positive, order TTR gene sequencing to distinguish hereditary from wild-type TTR amyloidosis 3
  • If monoclonal protein is present or PYP is negative, endomyocardial biopsy with Congo red staining and mass spectrometry is required 3

For sarcoidosis:

  • 18F-FDG PET scan shows patchy myocardial uptake 3
  • Serum ACE level, chest CT for pulmonary involvement 3
  • Endomyocardial biopsy may show non-caseating granulomas 3

For hemochromatosis:

  • Serum ferritin, transferrin saturation, and iron studies 2
  • Cardiac MRI with T2 imaging* quantifies myocardial iron deposition 3
  • HFE gene testing for hereditary hemochromatosis 3

For familial restrictive cardiomyopathy:

  • Detailed family history of cardiomyopathy or sudden death 2, 5
  • Genetic testing for sarcomeric protein mutations (cTnI, cTnT, MyBP-C, MYH7, DES, FLNC) if family history is positive or patient is younger 5, 6

Step 4: Cardiac Catheterization if Diagnosis Remains Unclear

Hemodynamic findings that favor restrictive cardiomyopathy over constriction:

  • LVEDP exceeds RVEDP by ≥5 mmHg at rest or with exercise 1
  • RV systolic pressure >50 mmHg (pulmonary hypertension from chronic left-sided disease) 1

Management Based on Etiology

If Constrictive Pericarditis:

Pericardiectomy is curative and should be performed early before advanced disease develops (higher mortality with delayed surgery) 1

If Cardiac Amyloidosis:

  • AL amyloidosis: Chemotherapy (bortezomib-based regimens) and autologous stem cell transplantation 1, 3
  • TTR amyloidosis: Tafamidis (stabilizes TTR tetramers), patisiran or inotersen (gene silencers) 3
  • Supportive care: Low-dose loop diuretics (avoid aggressive diuresis as these patients are preload-dependent), avoid digoxin and calcium channel blockers (bind to amyloid fibrils), consider anticoagulation for atrial fibrillation even without documented arrhythmia 3

If Hemochromatosis:

Phlebotomy or iron chelation therapy (deferoxamine, deferasirox) can reverse cardiomyopathy if started early 1

If Sarcoidosis:

Corticosteroids (prednisone 20-40 mg daily) with or without immunosuppressants (methotrexate, azathioprine) 3

If Idiopathic or Other Causes:

Supportive therapy only:

  • Diuretics for volume management (use cautiously as these patients are preload-dependent) 1, 3
  • Beta-blockers or calcium channel blockers for heart rate control to maximize diastolic filling time 3
  • Anticoagulation if atrial fibrillation develops 3
  • Consider heart transplantation in refractory cases, particularly in younger patients 6

Critical Pitfalls to Avoid

  • Do not assume all restrictive physiology is myocardial disease—always rule out constrictive pericarditis first, as it is surgically curable 1
  • Do not delay pericardiectomy in advanced constrictive pericarditis waiting for prolonged anti-inflammatory trials 4
  • Do not use digoxin or calcium channel blockers in suspected amyloidosis—they bind to amyloid fibrils and cause toxicity 3
  • Do not aggressively diurese—these patients are preload-dependent and can develop hypotension and renal failure 3
  • Do not miss TTR amyloidosis—PYP scan is highly specific and can diagnose without biopsy if no monoclonal protein is present 3

References

Guideline

Distinguishing Constrictive Pericarditis from Restrictive Cardiomyopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Restrictive cardiomyopathy: definition and diagnosis.

European heart journal, 2022

Guideline

CRP Elevation in Constrictive Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.